Select Medical (NYSE:SEM) Issues FY 2025 Earnings Guidance

Select Medical (NYSE:SEM - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.090-1.190 for the period, compared to the consensus earnings per share estimate of 1.430. The company issued revenue guidance of $5.4 billion-$5.6 billion, compared to the consensus revenue estimate of $5.8 billion.

Select Medical Stock Up 4.7 %

NYSE SEM traded up $0.83 during mid-day trading on Monday, reaching $18.51. The stock had a trading volume of 1,225,852 shares, compared to its average volume of 871,570. The stock has a market cap of $2.40 billion, a PE ratio of 11.22, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The company has a fifty day moving average price of $19.07 and a 200 day moving average price of $27.81. Select Medical has a 1 year low of $16.20 and a 1 year high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last announced its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). The company had revenue of $1.31 billion for the quarter, compared to analysts' expectations of $1.50 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. On average, research analysts expect that Select Medical will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd will be paid a dividend of $0.0625 per share. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a yield of 1.35%. Select Medical's dividend payout ratio is presently 30.30%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. UBS Group decreased their target price on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating for the company in a research note on Friday, January 3rd. Royal Bank of Canada cut their price objective on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a research report on Monday. Benchmark raised shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective for the company in a research report on Monday. Finally, StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research report on Friday. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $27.25.

Insider Activity

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of the company's stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company's stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Marilyn B. Tavenner sold 32,000 shares of the company's stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now directly owns 22,000 shares of the company's stock, valued at $463,980. This represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. Insiders own 19.14% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.